Dow Jones decreases despite the wider set, as a Healthcare stock tank at Trump’s account

Dow Jones lost 178 points, dragged with reduced expectations of gains from major American health firms.

Markets Stock Exchange are gathered thanks to China-American tariff de-escalation, but the Dow Jones is still lagging behind. On Tuesday, 13. Maja, S & P 500 was at 5,893 points, in the amount of 50 points or 0.85%, entering a positive territory in a year of 2025. Years. The technical focused Name was traded 21,222.80, on the rise of 21,222.80, on the rise of 21,222.80, on the rise from 21.62.80.

At the same time, Dov Jones was at 42,250.67 points, down 159.43 or 0.38%. This is despite the fact that positive events in American trade relations have increased technological action. For example, Nvidia rose 5.79%, Amazon rose 1.64%, while IBM gained 1.87%.

Health care actions hit Trump’s new move

However, gains from Nvidia and Amazone surpassed by Microsoft loss of 0.28%, as well as significant losses from health firms. For example, Johnson and Johnson lost 3.04%, while Merck lost 3.18%, both companies involved in healthcare.

What is more, UnitedHealth lost a stunning 16.34% after an abruptly Until his long years of Executive Director, Andrew Vitti. The company also suspended its annual pricing forecast, referring to the increase in medical decision costs.

Health care actions were on decline after American President Donald Trump signed the executive order whose goal is to reduce the price of prescription drugs. The administration is addressed to companies to reduce drug prices similar to the levels of what patients in other countries pay. For those who are not abiding, the white house threatened escalating, yet unspecified measures to keep them all right.

Analysts are estimated This cutting of drug prices could have reduced 2028 net income for the world pharmaceutical industry by 8%. However, while the move in the profit of health firms, it could be facilitated by Americans who fight the growing health care costs.